Article: Minimal-access parathyroid surgery using intraoperative parathyroid hormone assay.
1998 Volume 108, Issue 10, Page(s) 1497–1503
Abstract: Objectives: Review the most current preoperative localization imaging techniques in patients with primary hyperparathyroidism and demonstrate their applicability to targeted tumor removal with intraoperative parathyroid hormone (PTH) monitoring.: ... ...
Abstract | Objectives: Review the most current preoperative localization imaging techniques in patients with primary hyperparathyroidism and demonstrate their applicability to targeted tumor removal with intraoperative parathyroid hormone (PTH) monitoring. Study design: Retrospective review of 40 consecutive patients undergoing parathyroid surgery with intraoperative PTH assay as the principal determinant of correction of the hyperparathyroid state. Details of the technology, cost analysis, and comparison with other management methods are discussed. Methods: The standard intact PTH chemiluminescent assay (Nichols Diagnostics) and modifications to allow accelerated intraoperative results are discussed in detail. The time intervals between completion of parathyroid excision and postremoval assay and subsequent laboratory investigation present a practical therapeutic algorithm. Results: Forty consecutive patients with hyperparathyroidism were treated surgically with intraoperative PTH as the determinant of satisfactory resolution of the disease state. In most instances, the surgical field was reduced to the targeted pathology identified by preoperative localization, and all patients became eucalcemic when this method was employed. Approximately half of eligible patients were treated under local anesthesia. Conclusions: Intraoperative PTH assay has added a new dimension to primary and revision parathyroid surgery. It is cost-effective and accurate and may reduce the morbidity of surgical intervention in revision procedures. |
---|---|
MeSH term(s) | Adenoma/blood ; Adenoma/diagnostic imaging ; Adenoma/surgery ; Algorithms ; Female ; Humans ; Hyperparathyroidism/surgery ; Immunoradiometric Assay/methods ; Luminescent Measurements ; Monitoring, Intraoperative ; Parathyroid Hormone/blood ; Parathyroid Neoplasms/blood ; Parathyroid Neoplasms/diagnostic imaging ; Parathyroid Neoplasms/surgery ; Pregnancy ; Pregnancy Complications, Neoplastic/blood ; Pregnancy Complications, Neoplastic/surgery ; Radionuclide Imaging ; Radiopharmaceuticals ; Retrospective Studies ; Technetium Tc 99m Sestamibi |
Chemical Substances | Parathyroid Hormone ; Radiopharmaceuticals ; Technetium Tc 99m Sestamibi (971Z4W1S09) |
Language | English |
Publishing date | 1998-10 |
Publishing country | United States |
Document type | Journal Article ; Research Support, U.S. Gov't, Non-P.H.S. |
ZDB-ID | 80180-x |
ISSN | 1531-4995 ; 0023-852X |
ISSN (online) | 1531-4995 |
ISSN | 0023-852X |
DOI | 10.1097/00005537-199810000-00013 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Ul II Zs.82: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.